Skip to main content
Premium Trial:

Request an Annual Quote

Masao Yoneyama, Edward Erickson

Premium
Affymetrix has appointed Masao Yoneyama as general manager of its Japanese operations.

He comes to Affy from Daiichi Pure Chemicals, where he was the general manager of business development.

Yoneyama has a BS in chemistry and an MS and PhD in toxicology from Utah State University.

 

 
BioTrove has appointed Edward Erickson to its board of directors, which BioTrove said “reflects [its] increased emphasis on diagnostics and services.”
 

Erickson is chairman of Immunicon. He has BS and MS degrees from the Illinois Institute of Technology and an MBA from the Harvard Business School

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.